Drugs that contain Plerixafor

1. List of Mozobil drug patents

MOZOBIL's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7897590 GENZYME Methods to mobilize progenitor/stem cells
Jul, 2023

(a month from now)

US6987102 GENZYME Methods to mobilize progenitor/stem cells
Jul, 2023

(a month from now)

Do you want to check out MOZOBIL patents from before 2022?

Market Authorisation Date: 15 December, 2008

Treatment: Use in combination with granulocyte-colony stimulating factor (g-csf) to mobilize hematopoietic stem cells to peripheral blood for collection & subsequent autologous transplantation in patients with n...

Dosage: SOLUTION;SUBCUTANEOUS

How can I launch a generic of MOZOBIL before it's patent expiration?
More Information on Dosage

MOZOBIL family patents

14

United States

4

Norway

4

European Union

3

Japan

2

Spain

2

Denmark

2

China

2

Canada

2

Korea, Republic of

2

Cyprus

2

Portugal

2

Netherlands

2

Lithuania

2

Luxembourg

2

Slovenia

1

Hong Kong

1

Austria

1

Germany

1

Poland

1

Russia

1

Brazil

1

New Zealand

1

Belgium

1

Israel

1

Mexico

1

Australia

1

South Africa

1

Hungary

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in